Terms: = Germ cell tumor AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2 AND Treatment
38 results:
1. Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Kirkwood JM; Vecchio MD; Weber J; Hoeller C; Grob JJ; Mohr P; Loquai C; Dutriaux C; Chiarion-Sileni V; Mackiewicz J; Rutkowski P; Arenberger P; Quereux G; Meniawy TM; Ascierto PA; Menzies AM; Durani P; Lobo M; Campigotto F; Gastman B; Long GV
Future Oncol; 2024 May; 20(15):959-968. PubMed ID: 38390818
[TBL] [Abstract] [Full Text] [Related]
2. Elucidation of GPR55-Associated Signaling behind thc and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma cells.
Kolbe MR; Hohmann T; Hohmann U; Maronde E; Golbik R; Prell J; Illert J; Strauss C; Dehghani F
Cells; 2023 Nov; 12(22):. PubMed ID: 37998380
[TBL] [Abstract] [Full Text] [Related]
3. Cytotoxic effects of Chartergellus communis wasp venom peptide against melanoma cells.
Bastos V; Pascoal S; Lopes K; Mortari M; Oliveira H
Biochimie; 2024 Jan; 216():99-107. PubMed ID: 37879427
[TBL] [Abstract] [Full Text] [Related]
4. Gene Profiling of
Poommarapan K; Rummaneethorn P; Srisubat A; Suwanpidokkul N; Leenutaphong P; Nararatwanchai T; Srihirun S; Phetchengkao W; Suriyachan K; Tancharoen S
Anticancer Res; 2023 Mar; 43(3):1221-1237. PubMed ID: 36854502
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of the Antitumor Potential of Extracts of
Sánchez-Sánchez L; García J; Fernández R; Noskova E; Egiguren-Ortiz J; Gulak M; Ochoa E; Laso A; Oiarbide M; Santos JI; Fe Andrés M; González-Coloma A; Adell A; Astigarraga E; Barreda-Gómez G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835247
[TBL] [Abstract] [Full Text] [Related]
6. Phytochemical Constituents and Derivatives of
Schanknecht E; Bachari A; Nassar N; Piva T; Mantri N
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614303
[TBL] [Abstract] [Full Text] [Related]
7. tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties.
Audrito V; Moiso E; Ugolini F; Messana VG; Brandimarte L; Manfredonia I; Bianchi S; De Logu F; Nassini R; Szumera-Ciećkiewicz A; Taverna D; Massi D; Deaglio S
J Transl Med; 2022 Mar; 20(1):118. PubMed ID: 35272691
[TBL] [Abstract] [Full Text] [Related]
8. Interaction of Glia cells with Glioblastoma and Melanoma cells under the Influence of Phytocannabinoids.
Hohmann U; Walsleben C; Ghadban C; Kirchhoff F; Dehghani F; Hohmann T
Cells; 2022 Jan; 11(1):. PubMed ID: 35011711
[TBL] [Abstract] [Full Text] [Related]
9. Novel Chemically Modified Curcumin (CMC) Analogs Exhibit Anti-Melanogenic Activity in Primary Human Melanocytes.
Goenka S; Simon SR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205035
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.
Kyriakou I; Yarandi N; Polycarpou E
Phytomedicine; 2021 Jul; 88():153533. PubMed ID: 33812759
[TBL] [Abstract] [Full Text] [Related]
11. Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.
Wang J; Li Z; Yin F; Zhang R; Zhang Y; Wang Z; Sheng X
Cancer Gene Ther; 2022 Mar; 29(3-4):253-263. PubMed ID: 33742130
[TBL] [Abstract] [Full Text] [Related]
12. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.
Lah TT; Novak M; Pena Almidon MA; Marinelli O; Žvar Baškovič B; Majc B; Mlinar M; Bošnjak R; Breznik B; Zomer R; Nabissi M
Cells; 2021 Feb; 10(2):. PubMed ID: 33562819
[TBL] [Abstract] [Full Text] [Related]
13. TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions.
Yang W; Wu PF; Ma JX; Liao MJ; Xu LS; Yi L
Sci Rep; 2020 Aug; 10(1):14151. PubMed ID: 32843668
[TBL] [Abstract] [Full Text] [Related]
14. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies.
Bachari A; Piva TJ; Salami SA; Jamshidi N; Mantri N
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839414
[TBL] [Abstract] [Full Text] [Related]
15. Targeting Glioma Initiating cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract] [Full Text] [Related]
16. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract] [Full Text] [Related]
17. The enhanced effect of tetrahydrocurcumin on radiosensitivity of glioma cells.
Zhang X; Peng L; Liu A; Ji J; Zhao L; Zhai G
J Pharm Pharmacol; 2018 Jun; 70(6):749-759. PubMed ID: 29492979
[TBL] [Abstract] [Full Text] [Related]
18. Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme cells Via Membranolytic Action.
da Silva AMB; Silva-Gonçalves LC; Oliveira FA; Arcisio-Miranda M
Mol Neurobiol; 2018 Jul; 55(7):5490-5504. PubMed ID: 28965321
[TBL] [Abstract] [Full Text] [Related]
19. Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.
Zeissler ML; Eastwood J; McCorry K; Hanemann CO; Zajicek JP; Carroll CB
Oncotarget; 2016 Jul; 7(29):46603-46614. PubMed ID: 27366949
[TBL] [Abstract] [Full Text] [Related]
20. Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma cells.
Scott KA; Dennis JL; Dalgleish AG; Liu WM
Anticancer Res; 2015 Nov; 35(11):5827-37. PubMed ID: 26504004
[TBL] [Abstract] [Full Text] [Related]
[Next]
